RE: A quick question3 Sep 2024 10:44
Admission and Total Voting Rights
Application has been made for the Fundraise Shares to be admitted to trading on AIM ("Admission"). It is anticipated that trading in the new shares will commence on AIM at or around 8.00 a.m. on 14 June 2024. The Fundraise Shares will rank pari passu with the existing Ordinary Shares in issue.
Following Admission, the Company's issued and fully paid share capital will consist of 5,315,710,763 Ordinary Shares, all of which carry one voting right per share. The Company does not hold any Ordinary Shares in treasury. Following Admission, the figure of 5,315,710,763 Ordinary Shares may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure Guidance and Transparency Rules.
As with the majority of placing/cln shares, many would have been FORWARD SOLD , from a p&d high on down towards the placing price, many a wonga (not remotely II or Investors in most cases) will even drop below the placing price, for a final clearance sale, having made more than their target from the high's down. Some play both ends additionally shorting down as they know it will happen they are controlling the game.
Clue is in the name Investor, they stick around for the journey ,not just the next spike, investing but rare as rocking horse 💩 Investors. Own agenda and stick to it, little interest in what a company may, or may not do in the future.
Overhang done or running on fumes, is when the meaty RNA message is usually dropped, wonga gets to finish/clear but does not hold back the market correction up/down as the news warrants, always a win win for them, not so much for us
🤔😂